Got it 👍 — I’ll prepare a **professional GitHub README.md** for your project based on the text you shared. Here’s a polished version:

---

# Integrative Multi-Omics Subtyping of Colon Adenocarcinoma Using Deep Learning and Explainable AI

This study leverages **deep learning** and **explainable AI** to integrate transcriptomic, copy-number, and DNA methylation data from **TCGA colon adenocarcinoma (COAD)**. The approach evaluates whether integrative clustering can uncover novel molecular subtypes, their prognostic relevance, and biologically interpretable signals.

---

## 📑 Abstract

This study investigates whether integrative clustering of colon adenocarcinoma (COAD) multi-omics data could reveal novel subtypes with prognostic or biological significance. Using a fused multi-omics representation, we applied **K-Means clustering**, **differential expression (DE)**, **SHAP explainability**, and **survival analysis**.

The best clustering solution was *k = 2* (silhouette = 0.1386), but cluster separation was modest. **Survival analysis** showed no significant difference (log-rank p = 0.5–0.75). While **DE analysis** and **SHAP feature importance** produced interpretable biological signals, no overlap was observed between DE and SHAP-selected genes.

Together, these findings suggest **weak subtype structure** in this cohort and highlight the value of explainable AI in capturing **multivariate signals** not detected by traditional DE analysis.

---

## 🧬 Background

* Colorectal cancer (CRC) is the **third most common malignancy** and the **second leading cause of cancer-related mortality worldwide**.
* Development involves genetic mutations (APC, KRAS, TP53), chromosomal instability, and epigenetic alterations.
* Current **Consensus Molecular Subtypes (CMS)** classify COAD into four groups:

  * **CMS1** (immune)
  * **CMS2** (canonical)
  * **CMS3** (metabolic)
  * **CMS4** (mesenchymal)

👉 Despite CMS, **heterogeneity** remains in prognosis and therapy response.
👉 Transcriptome-only studies miss signals from **DNA methylation** and **CNV**.
👉 **Multi-omics integration** may refine stratification and reveal novel therapeutic targets.

---

## ⚙️ Methods

1. **Data Preprocessing**

   * RNA-seq, CNV, and methylation data downloaded from TCGA.
   * Normalized and embedded into a **fused latent representation**.

2. **Variational Autoencoder (VAE)**

   * Captured complex, non-linear relationships across modalities.
   * Learned **low-dimensional latent embeddings**.

3. **Clustering**

   * Applied **K-Means** (k=2–6).
   * Evaluated with **silhouette scores**.
   * Tested **HDBSCAN** for robustness.

4. **Visualization**

   * **UMAP embedding** with cluster labels.

5. **Survival Analysis**

   * Kaplan–Meier curves.
   * Log-rank test for survival differences.

6. **Differential Expression (DE)**

   * Conducted between *k=2* clusters.
   * Standard RNA-seq workflow applied.

7. **Explainability (SHAP)**

   * Trained a classifier on the fused space.
   * Used **SHAP** to identify top-contributing genes.

8. **STRING Network**

   * Constructed **gene–gene interaction networks**.

---

## 📊 Results

* **Clustering**: Weak structure (*silhouette \~0.14*).
* **Survival analysis**: No significant prognostic separation (*p \~0.5–0.75*).
* **DE analysis**: Identified biologically interpretable genes.
* **SHAP explainability**: Highlighted immune, ECM, and metabolic regulators.
* **Key insight**: No overlap between DE and SHAP genes → **multivariate interactions vs. univariate differences**.

---

## 🧾 Conclusions

* Integrative clustering does **not uncover strong new COAD subtypes** in this cohort.
* SHAP and explainable AI provide **orthogonal biological insights** missed by DE.
* Findings suggest the need for:

  * Larger, harmonized **multi-omics cohorts**.
  * **Pathway-level SHAP integration**.
  * Experimental validation of **immune and ECM regulators**.

---

## 📌 Future Directions

* Expand to larger independent cohorts.
* Apply **transfer learning/imputation** to address missing data.
* Functional studies on highlighted biomarkers.

---

## 📂 Repository Structure

```
.
├── data/               # Processed input data (RNA-seq, CNV, methylation)
├── notebooks/          # Jupyter notebooks for analysis
├── src/                # Scripts for preprocessing, modeling, and evaluation
├── results/            # Outputs (plots, tables, survival curves, SHAP, DE results)
├── README.md           # Project documentation
└── requirements.txt    # Python dependencies
```

---

## 🚀 Installation & Usage

```bash
# Clone repo
git clone https://github.com/yourusername/Integrative-Multi-Omics-Subtyping-COAD.git
cd Integrative-Multi-Omics-Subtyping-COAD

# Install requirements
pip install -r requirements.txt

# Run analysis
jupyter notebook notebooks/main_analysis.ipynb
```

---

## 📖 References

Kingma, D.P. and Welling, M., 2014. Auto-encoding variational Bayes. Proceedings of the 2nd International Conference on Learning Representations (ICLR), Banff, Canada.


Way, G.P. and Greene, C.S., 2018. Extracting a biologically relevant latent space from cancer transcriptomes with variational autoencoders. Pacific Symposium on Biocomputing, 23, pp.80-91.


Chaudhary, K., Poirion, O.B., Lu, L. and Garmire, L.X., 2018. Deep learning–based multi-omics integration robustly predicts survival in liver cancer. Clinical Cancer Research, 24(6), pp.1248-1259.


Zhang, L., Lv, C., Jin, Y., Cheng, G., Fu, Y., Yuan, D., Tao, Y. and Guo, Y., 2019. Deep learning-based multi-omics data integration reveals two prognostic subtypes in high-risk neuroblastoma. Frontiers in Genetics, 10, p.532.


Simidjievski, N., Bodnar, C., Tariq, I., Scherer, P., Andres Terre, H., Shams, Z. and Liò, P., 2019. Variational autoencoders for cancer data integration: design principles and computational practice. Frontiers in Genetics, 10, p.1205.
Guinney, J. et al., 2015. The consensus molecular subtypes of colorectal cancer. Nature Medicine, 21(11), pp.1350–1356.


Muzny, D.M. et al., 2012. Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487, pp.330–337.


Huang, S.S., et al., 2013. Linking proteomic and transcriptional data through the interactome and epigenome reveals a map of oncogene-induced signaling. PLOS Computational Biology, 9(2), e1002873.


Hasin, Y., Seldin, M. & Lusis, A., 2017. Multi-omics approaches to disease. Genome Biology, 18(1), 83.


Frontiers Immunol., 2025. Cross-cohort multi-omics analysis identifies novel clusters driven by VEGFA+TC signatures in colorectal cancer. Frontiers in Immunology, 16, article 1628005. Frontiers


Wang, J. et al., 2025. Integrative analysis of multi-omics data and gut microbiota composition reveals prognostic subtypes in CRC. Research Square. DOI: 10.21203/rs.3.rs-5669193/v1. Research Square


Frontiers Immunol., 2023. Identification of immunotherapy and chemotherapy-related subtypes in colon cancer by integrative multi-omics and pathway genes. Frontiers in Immunology. Frontiers


Wikipedia, 2025. Tumour heterogeneity. Tumour heterogeneity: computational modeling perspectives. Wikipedia


Wikipedia, 2025. The Cancer Genome Atlas. TCGA: integrated omics characterization of colorectal cancer. Wikipedia


Wikipedia, 2025. Multiomics. Multi-omics integration in health and disease research. Wikipedia
Wang, J. et al., 2025. Comprehensive evaluation of multi-omics clustering algorithms for cancer molecular subtyping. International Journal of Molecular Sciences, 26(3), 963. MDPI


ResearchSquare, 2024. Benchmarking multi-omics integrative clustering methods for subtype identification in colorectal cancer. (Preprint). Research Square+1


medRxiv, 2025. Explainable AI for precision oncology: imaging, multi-omics and clinical data. medRxiv. DOI:10.1101/2025.07.12.25331423v1. MedRxiv+1


MDPI Sensors, 2025. Explainable AI in cancer: stacking ensemble with SHAP interpretations across cancers. Sensors, 12(5), 472. MDPI


arXiv, 2025. Layer-aware SHAP manifold for survival signal stratification in pan-cancer. arXiv preprint 2504.10343. arXiv


ScienceDirect, 2024. Decoding the black box: trends and applications of explainable AI in cancer care. Artificial Intelligence in Medicine. ScienceDirect


Harper, et al., 2025. Integrated explainable machine learning and multi-omics in melanoma classification and immune response. Apoptosis. SpringerLink


Research Square, 2025. Integrative analysis of multi-omics and microbiota in CRC for subtype and prognosis modeling. Research Square. Research Square


arXiv, 2019. OncoNetExplainer: explainable predictions of cancer types using SHAP and CNNs. arXiv preprint 1909.04169. arXiv


arXiv, 2023. Cancer subtype identification via integration of inter- and intra-omics datasets (LIDAF). arXiv preprint 2312.02195. arXiv


arXiv, 2024. Explainable AI in breast cancer detection and risk prediction: a systematic scoping review. arXiv preprint 2407.12058. arXiv


arXiv, 2023. Explainable ML framework for accurate ovarian cancer diagnosis: SHAP usage. arXiv preprint 2312.08381. arXiv


Frontiers Immunol., 2025. Multi-omic explainable machine learning for cancer diagnostics: abstract form. Clinical Cancer Research, 31(13_Supplement):A051. AACR Journals


Wikipedia, 2025. Single-cell multi-omics integration. Single-cell multi-omics computational methods. Wikipedia


BBC, 2010. Cancer systems biology approaches for integrative cancer modeling. Cancer Systems Biology. Wikipedia


Frontiers in Immunology, 2025. Multi-cohort CRC clustering driven by VEGFA+TC signatures. Frontiers


International Journal of Molecular Sciences, 2025. Evaluation framework for multi-omics cancer clustering. MDPI


Sensors MDPI, 2025. Enhancing cross-cancer predictions with SHAP interpretability. MDPI


medRxiv, 2025. Task-specific AI leverages multi-omics for precision oncology with SHAP explanations. MedRxiv


ScienceDirect, 2024. SHAP and LIME in melanoma multi-omics explainability. SpringerLink

---

🔗 **GitHub Repository:** \[Add your repo link here]

---

Would you like me to also prepare a **condensed version** (short README style for GitHub) or keep this **long scientific version** only?
